Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) EPS (Basic): 2020-2025

Historic EPS (Basic) for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$0.09.

  • Journey Medical's EPS (Basic) rose 25.00% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 62.77%. This contributed to the annual value of -$0.72 for FY2024, which is 242.86% down from last year.
  • Latest data reveals that Journey Medical reported EPS (Basic) of -$0.09 as of Q3 2025, which was up 43.75% from -$0.16 recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's EPS (Basic) peaked at $0.91 during Q3 2023, and registered a low of -$1.89 during Q4 2021.
  • For the 3-year period, Journey Medical's EPS (Basic) averaged around -$0.13, with its median value being -$0.16 (2025).
  • As far as peak fluctuations go, Journey Medical's EPS (Basic) crashed by 775.00% in 2021, and later surged by 259.65% in 2023.
  • Journey Medical's EPS (Basic) (Quarterly) stood at -$1.89 in 2021, then surged by 68.25% to -$0.60 in 2022, then skyrocketed by 80.00% to -$0.12 in 2023, then soared by 166.67% to $0.08 in 2024, then climbed by 25.00% to -$0.09 in 2025.
  • Its EPS (Basic) was -$0.09 in Q3 2025, compared to -$0.16 in Q2 2025 and -$0.18 in Q1 2025.